Logo image of POCI

PRECISION OPTICS CORP INC (POCI) Stock Fundamental Analysis

NASDAQ:POCI - Nasdaq - US7402944000 - Common Stock - Currency: USD

4.9  -0.09 (-1.8%)

Fundamental Rating

1

Taking everything into account, POCI scores 1 out of 10 in our fundamental rating. POCI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. POCI may be in some trouble as it scores bad on both profitability and health. POCI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year POCI has reported negative net income.
In the past year POCI has reported a negative cash flow from operations.
POCI had negative earnings in each of the past 5 years.
In the past 5 years POCI reported 4 times negative operating cash flow.
POCI Yearly Net Income VS EBIT VS OCF VS FCFPOCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M

1.2 Ratios

Looking at the Return On Assets, with a value of -29.50%, POCI is in line with its industry, outperforming 43.32% of the companies in the same industry.
POCI has a Return On Equity (-43.93%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -29.5%
ROE -43.93%
ROIC N/A
ROA(3y)-7.91%
ROA(5y)-9.57%
ROE(3y)-13.61%
ROE(5y)-19.08%
ROIC(3y)N/A
ROIC(5y)N/A
POCI Yearly ROA, ROE, ROICPOCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

With a Gross Margin value of 20.59%, POCI is not doing good in the industry: 79.68% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of POCI has remained more or less at the same level.
POCI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-0.54%
POCI Yearly Profit, Operating, Gross MarginsPOCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

2

2. Health

2.1 Basic Checks

POCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
POCI has about the same amout of shares outstanding than it did 1 year ago.
POCI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for POCI is higher compared to a year ago.
POCI Yearly Shares OutstandingPOCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
POCI Yearly Total Debt VS Total AssetsPOCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -0.13, we must say that POCI is in the distress zone and has some risk of bankruptcy.
POCI has a Altman-Z score (-0.13) which is in line with its industry peers.
A Debt/Equity ratio of 0.11 indicates that POCI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.11, POCI is in line with its industry, outperforming 58.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -0.13
ROIC/WACCN/A
WACC8.66%
POCI Yearly LT Debt VS Equity VS FCFPOCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 1.99 indicates that POCI should not have too much problems paying its short term obligations.
POCI's Current ratio of 1.99 is on the low side compared to the rest of the industry. POCI is outperformed by 65.24% of its industry peers.
A Quick Ratio of 1.26 indicates that POCI should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.26, POCI is not doing good in the industry: 69.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.26
POCI Yearly Current Assets VS Current LiabilitesPOCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

POCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -134.21%.
POCI shows a decrease in Revenue. In the last year, the revenue decreased by -9.18%.
The Revenue has been growing by 22.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-134.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
Revenue 1Y (TTM)-9.18%
Revenue growth 3Y21.43%
Revenue growth 5Y22.95%
Sales Q2Q%-20.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
POCI Yearly Revenue VS EstimatesPOCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
POCI Yearly EPS VS EstimatesPOCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

POCI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
POCI Price Earnings VS Forward Price EarningsPOCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
POCI Per share dataPOCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

POCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PRECISION OPTICS CORP INC

NASDAQ:POCI (7/24/2025, 8:00:00 PM)

4.9

-0.09 (-1.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)09-29 2025-09-29
Inst Owners31.47%
Inst Owner Change0%
Ins Owners16.68%
Ins Owner Change11.04%
Market Cap37.58M
AnalystsN/A
Price TargetN/A
Short Float %0.89%
Short Ratio2.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.13
P/FCF N/A
P/OCF N/A
P/B 2.85
P/tB 9.13
EV/EBITDA N/A
EPS(TTM)-0.89
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS2.3
BVpS1.72
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.5%
ROE -43.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.59%
FCFM N/A
ROA(3y)-7.91%
ROA(5y)-9.57%
ROE(3y)-13.61%
ROE(5y)-19.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-0.54%
F-Score3
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.42%
Cap/Sales 1.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.26
Altman-Z -0.13
F-Score3
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)80.38%
Cap/Depr(5y)93.32%
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-134.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.18%
Revenue growth 3Y21.43%
Revenue growth 5Y22.95%
Sales Q2Q%-20.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-180.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1251.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-923.79%
OCF growth 3YN/A
OCF growth 5YN/A